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Abstract: Human T-lymphotropic viruses type 1 (HTLV-1) and type 2 (HTLV-2) present 
very similar genomic structures but HTLV-1 is more pathogenic than HTLV-2. Is this 
difference  due  to  their  transactivating  Tax  proteins,  Tax-1  and  Tax-2,  which  are 
responsible  for  viral  and  cellular  gene  activation?  Do  Tax-1  and  Tax-2  differ  in  their 
cellular localization and in their interaction pattern with cellular factors? In this review, we 
summarize Tax-1 and Tax-2 structural and phenotypic properties, their interaction with 
factors involved in signal transduction and their localization-related behavior within the 
cell. Special attention will be given to the distinctions between Tax-1 and Tax-2 that likely 
play an important role in their transactivation activity. 
Keywords:  HTLV;  Tax-1;  Tax-2;  signal  transduction;  cellular  localization;  
post-translational modifications; NF-B; PDZ binding motif 
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1. Introduction  
Human T-lymphotropic viruses type 1 (HTLV-1) and type 2 (HTLV-2) are closely related human 
retroviruses. HTLV-1 is tropic for CD4
+ and HTLV-2 preferentially infects CD8
+ T-cells [1]. HTLV-1 
is  the  etiologic  agent  of  adult  T-cell  leukemia/lymphoma  (ATLL)  and  of  HTLV-1-associated 
myelopathy/tropical spastic paraparesis (HAM/TSP)  [2]. As yet, HTLV-2 is not known  to have a 
precise  pathologic  role,  and  is  not  associated  with  any  malignancies  but  only  with  rare  cases  of 
subacute myelopathy resembling HAM/TSP [3]. In addition to gag, pol, and env genes, HTLV-1 and 
HTLV-2 encode tax/rex and several accessory genes from the pX ORF located in the 3' region of the 
genome [1,4]. The minus strands of HTLV-1 and HTLV-2 also code for proteins involved in cell 
proliferation, HBZ (HTLV-1 B-Zip protein) and APH-2 (HTLV-2 encoded antisense protein) [5,6]. 
HTLV-1 and HTLV-2 infectivity and transformation capacity appears to differ from that exerted by 
other  animal  retroviruses  in  that  tumor  development  is  not  mediated  by  the  presence  of  a  viral 
oncogene or by the activation of a cellular proto-oncogene. Since HTLV is transmitted essentially 
through cell to cell contact and both viruses have the capability of inducing T-cell transformation [7,8], 
the ability of the oncogenic Tax proteins of HTLV-1 (Tax-1) and HTLV-2 (Tax-2) to induce cell 
proliferation becomes essential. In fact, Tax-1 plays a central role in triggering transforming activity, 
acting as a potent transcriptional activator of both viral and cellular genes [9]. More generally this 
molecule displays pleiotropic activities through the interaction with cellular transcriptional factors and 
signaling pathways which have been intensively studied [2,10]. This variety of effects concurs to the 
induction of neoplastic transformation by activating the expression of cytokines responsible for T cell 
proliferation [11], by abrogating DNA repair [12], thus increasing mutation load and DNA damage, 
and by suppressing apoptosis [13]. Recent studies have shown that Tax-1 transgenic mice develop T 
cell lymphomas, demonstrating that Tax is capable by itself of inducing an oncogenic effect in vivo 
[14,15].  Although  the  etiologic  difference  in  pathogenic  properties  of  HTLV-1  and  HTLV-2  still 
remains unclear,  it  has  been  suggested  that  it  could  be  attributed  to  the  differential  structure  and 
activities  of  their  transactivating  Tax  proteins.  An  impressive  body  of  evidence  has  already  been 
obtained  suggesting  that  Tax-1  is  involved  in  survival  of  HTLV-1  infected  T-cells,  in  cell  cycle 
progression and genome instability [10,12,16–19]. In this review, we will not discuss all different 
facets of Tax-1 effects, rather we will focus on common features and functional differences of Tax-1 
and  Tax-2  for  which sufficient  information has  so  far  being  accumulated,  with the  main view  of 
updating recent reports and reviews [20]. 
Tax-1 and Tax-2 share an amino acid similarity of 85%. However, they present distinct phenotypic 
differences consistent with a more robust transformation capacity of Tax-1 in comparison to Tax-2 
[1,21]. Compared to Tax-2, Tax-1 transactivates the viral LTR promoter with higher efficiency and has 
a unique capacity to induce micronuclei formation [22]. In addition, Tax-1 arrests the cell cycle of 
human CD34
+ cells [23], suppresses hematopoiesis [13] and regulates gene expression through histone 
modifications [24,25]. Tax-2 was shown to be impaired for the inhibition of p53 functions [26] and to 
less efficiently transform rat embryo fibroblasts [21]. We have contributed to a report demonstrating 
that Tax-2 activation of HTLV-2 LTR is strongly inhibited by the MHC class II transactivator (CIITA) 
[27]. More recently, Tosi et al. [28] have shown that Tax-2 differs from Tax-1 since it is using CBP 
and p300 but not PCAF to enhance LTR transactivation. In a recent work, Li and Green [29] found Viruses 2011, 3                         
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that  total  viral  mRNA  expression  was  significantly  higher  for  HTLV-1  than  HTLV-2,  which  is 
consistent with a previous finding that HTLV-1 has stronger Tax transactivating activity than HTLV-2 
[9]. Tax-1 expression, as compared to Tax-2, resulted in higher levels of proinflammatory cytokine 
expression in human astrocytomas [11]. 
2. Protein Structure 
The protein structure of Tax-1 and Tax-2 is presented as a scheme in Figure 1. Of the four serotype 
of HTLV-2, Tax-2 of subtype A and type B are the best characterized [30]. Tax-2A has 331 amino 
acid (aa) residues, whereas Tax-2B presents a 25 aa C-terminal extension [31,32]. The Tax-2 structure 
depicted in Figure 1 is that of Tax-2B with 356 aa, being very close to that of Tax-1, which is 353 aa 
long. Tax-1 and Tax-2 have several common domains, even though the information for Tax-1 is by far 
more complete. The N-terminal region of Tax-1 protein contains a CREB-binding region, a zinc-finger 
domain,  and  binding  domains  required  for  interaction  with  proteasomal  subunits,  transcriptional 
coactivators,  and  proteins  involved  in  transcription,  cell  cycle  progression,  and  in  cell  signaling 
regulations [1]. The first 60 aa of Tax-1 also contains a nuclear localization signal (NLS) [33,34], 
whereas we have mapped a nuclear localization determinant (NLD) in the first 42 aa of Tax-2 [35]. 
Furthermore, in Tax-2, an additional localization domain of about 10 aa at position 89-113 has been 
demonstrated to be responsible for the divergent cellular localization as compared to Tax-1 [36].  
Figure 1. Structural and functional domains of Tax-1 and Tax-2. Specific domains, and the 
regions involved in transcriptional activation pathways are indicated.  
 
 
The central portion of Tax-1 contains two leucine zipper-like motifs at aa position 116–145 and 
213–248 [17], necessary for interacting with DNA, as well as for protein dimerization [37,38].  
This region also presents binding domains for proteins involved in histone methylation, cell cycle 
progression  and  in  cell  signaling  transduction  [17,34,39–42].  The  central  region  of  Tax-1  is  also 
directly involved in NF-B activation [17,43–47] association and p300 binding. The Tax-1 region 
encompassing aa 225–232, overlapping with the leucine zipper like region (LZR), is responsible for Viruses 2011, 3                         
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Tax1-mediated p100 processing and p52 nuclear translocation [48,49]. This sequence is not present 
within Tax-2, so that Tax-2 is unable to interact and process p100 [48,50]. Thus a Tax-2 LZR region 
involved in NF-ΚB2 activation has not been characterized. Another domain, which is common to the 
two  proteins,  is  the  nuclear  export  sequence  (NES)  at  amino  acid  position  189-202  [43,51].  The 
C-terminal  region  is  characterized  by  the  presence  in  both  Tax-1  and  Tax-2  of  an  ATF/CREB 
activating  domain,  essential  for  transactivation  of  the  CREB/ATF  and  for  NF-κB/Rel  signaling 
pathways [52]. 
Secretory  signals  are  present  at  the  C-terminal  part  of  Tax-1  that  confers  to  the  protein  the 
capability to egress from the endoplasmic reticulum and to migrate to the Golgi apparatus [53,54]. 
The presence of a class I PDZ binding motif (PBM) at the C-terminal end of Tax-1 and not in Tax-2 
is of particular interest. It allows Tax-1 but not Tax-2B to interact with many cellular factors, mostly of 
them being scaffolding proteins (reviewed in [20]).  
3. Tax-1 and Tax-2 Interaction with Factors Involved in Signal Transduction 
Protein-protein interactions represent a relevant issue for deciphering Tax protein functions and its 
capability to perturb the regulation of cellular
 pathways. Tax-1 interacts with several factors that are 
components of the cell signaling system, that control activities strictly linked to cell transformation, 
including  proliferation,  intracellular  protein  distribution,  cell  migration  and  virological  synapses 
[10,19,55,56].  Representative  Tax-interacting  cellular  proteins  together  with  their  corresponding 
signaling pathways (G proteins, MAPK, JNK, AP1, TGFβ, and NF-B signaling) are shown in Table 1 
[47,57–65]. Whereas more than 100 proteins have been identified that interact with Tax-1 [17], only a 
restricted number of Tax-2 interactions are known and the greater part of them are involved in the 
NF-B  pathway.  Therefore,  to  describe  and  compare  Tax-1  and  Tax-2B  involvement  in  signal 
transduction, we will focus mainly to Tax-protein interaction with NF-B factors. 
Table 1. Cell signaling factors interacting with Tax-1. 
Pathways  Factors  Reference 
G proteins 
Gβ subunit 
RhoGTPases 
[47,66] 
MAPKs 
MEKK1 
TAK1 
[59,61] 
JNK   GPS2  [61] 
AP1   p85α  [67] 
TGFβ 
Smad2 
Smad3 
Smad4 
[64] 
[64] 
[64] 
NF-ΚB 
IKKα 
IKKβ 
IKKγ 
IBα 
IBγ 
[65] 
[65] 
[65] 
[68] 
[69] 
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The activation of NF-B pathway is essential for Tax-mediated transformation of human T-cell 
lines by HTLV-1 and HTLV-2. Both Tax-1 and Tax-2 activate gene expression via NF-B [70–72]. Of 
the two NF-B-signaling pathways that mediate the transcriptional activation, the so-called canonical 
and  non  canonical,  Tax-1  has  been  shown  to  deregulate  both  pathways  by  interacting  with  and 
activating  several  factors,  including  RelA  and  IB  kinase  complex  (e.g.,  IKK,  IKK,  and 
NEMO/IKK) of the canonical signaling cascade [17], as well as p100, precursor of the non-canonical 
pathway (Figure 2A). The role of RelA in Tax-1-mediated activation of NF-B has been analyzed in 
several published works. It has been shown that Tax-1 interacts with the Rel homology domain of 
RelA  [73]  and  co-localizes  with  the  NF-B  subunit  RelA,  the  splicing  factors  Sm  and  
SC-35 and the large subunit of RNA polymerase II in nuclear structures called nuclear bodies. [74–76]. 
Tax-1 interaction has been reported with TAK1-binding-protein 2 (TAB2) [77]. The expression of 
TAB2 increases in HTLV-1-transformed cells [77]. Tax-1 is present in the Golgi-associated lipid raft 
microdomains  and  directs  IKK  complex  and  Tak1  translocation  to  lipid  raft  through  selective 
interaction with NEMO/IKKγ [71]. Compared to Tax-1, Tax-2 interacts with NEMO/IKK and the 
related proteins NRP/Optineurin [36,78] but does not recognize p100 [48] (Figure 2B). Moreover, like 
Tax-1,  Tax-2  can  associate  to  lipid  rafts,  but  does  not  possess  the  ability  to  direct  the  lipid  raft 
translocation of IKK [71]. Recently, we have provided evidence that Tax-2B, like Tax-1, is capable of 
interacting with additional factors of the NF-B pathway, namely RelA and TAB2 [70], which do not 
associate  with  each  other  [79]. We  have  also shown  that,  in different  cell  types,  both  Tax-1  and  
Tax-2B relocalize RelA to cytoplasmic dotted structures which include TAB2, while in cells that do 
not  express  Tax  proteins,  overexpressed  TAB2  does  not  co-localize  with  the  diffuse  cytoplasmic 
distributed RelA [70]. In addition, we showed that co-expression of RelA or TAB2 with Tax-1 or  
Tax-2B, synergistically  enhanced NF-B  activity.  Although it  is still  not  clear  the  mechanism  by 
which Tax proteins hijack NF-B factors in the cytoplasm, it is plausible that both Tax proteins endow 
new properties to cellular proteins interacting with them. A similar property has been attributed to  
Tax-induced  novel  interaction  between  RelA  and  p53  that  results  in  the  deregulation  of  p53 
transcriptional activity [80]. 
4.  Post-Translational  Modifications:  Phosphorylation,  Ubiquitination,  Sumoylation  and 
Acetylation  
4.1. Tax Phosphorylation and its PDZ Binding Motif (PBM) 
So far, six Tax-1 residues were identified as phosphorylation targets: Thr-48, Thr-184, Thr-215, 
Ser-300,  Ser-301  and  Ser-336  [81,82].  Serines  at  position  300  or  301  are  essential  for  gene 
transcription and their phosphorylation is required in order to activate Tax-1 [81] and to consequently 
allow  post-translational  modifications  such  as  ubiquitination,  sumoylation  and  acetylation  [83]. 
Phosphomimicking mutation at Thr-215 resulted in Tax-1 inhibition and mutations at Thr-48 impaired 
activation of NF-κB pathway, whereas mutations at Thr-184 and Ser-336 were found to be silent.  
Recently,  Jeong  et  al.  [84]  provided  indirect  evidence  that  Tax-1  phosphorylation  at  Ser-160 
stabilizes Tax-1. The interaction of Tax-1 phosphoSerine-Proline motif with the prolyl isomerase Pin1 Viruses 2011, 3                         
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inhibited its ubiquitination and its lysosomal degradation. Ser-160 and Pro-161 were already identified 
as essential residues for the activity of Tax-1 by mutational analysis [85,86]. 
Figure 2. Tax-1 and Tax-2 interaction with NF-B pathway. Schematic representation of 
the main steps in NF-B pathaway. Non-canonical NF-B activation involves the action of 
NF-B  inducing  kinase  (NIK)  and  IKKα  subunit  (α)  and  results  in  the  C-terminal 
proteosomal degradation of p100 in p52 and in the nuclear translocation of NF-B dimers 
containing p52. In the nucleus, the p52/RelB dimers induce gene expression, whereas p52 
homodimers or acetylated p52/RelA heterodimers turn off gene transcription. Canonical 
NF-B  activation  triggers  a  phosphorylation  cascade  involving kinases  such  as  TAK1, 
adaptor proteins such as TAB2, and the IKK complex (here schematized as α, β and γ), and 
results  in  proteosomal  degradation  of  cytoplasmic  inhibitors  (IB)  and  in  nuclear 
translocation of NF-B dimers (mainly RelA/p50). In the nucleus, the RelA/p50 dimers 
induce gene expression for cytokines, enzymes and adhesion molecules. (A) Blue arrows 
identify Tax-1 interactions with NF-B pathway factors; (B) Green arrows identify Tax-2 
interactions or absence of interaction (red X) with NF-B pathway factors. 
 
 
The phosphorylation state of Tax-2B is still unknown, even though it presents 85% homology to 
Tax-1 for the sequences surrounding the aforementioned phosphorylated residues, which are conserved 
with  the  exception  of  Ser-336.  We  have  recently  found  that  CK2  phosphorylates  Tax-1  Ser-336,  
Ser-344 and Thr-351 in vitro [87]. Compared to Tax-1, Tax-2 was found not to be phosphorylated by 
CK2 in vitro. 
Tax-1  C-terminus,  which  contains the  class I  PDZ  binding  motif  (PBM,  X-S/T-X-V,  where  X 
represents any aa) is completely different from that of Tax-2B. Thus it allows Tax-1, but not Tax-2B, Viruses 2011, 3                         
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to interact with many cellular factors, mostly scaffolding proteins, such as human disc large (hDlg), 
human homolog Scrib (hScrib),  membrane-associated guanylate kinase-3 (MAGI-3), pro-IL16 and 
Erbin (reviewed in [20]). Disruption of hDlg or hScrib activity by Tax-1 through PDZ interaction 
revealed their function as tumor suppressors [88,89]. Tax-1 PBM phosphorylation could modulate 
PDZ-mediated interactions [87]. Interestingly, removal or loss-of-function mutations of PBM motif did 
not  affect  Tax-1  activation  properties,  but  impeded  the  interaction  with  the  tumor  suppressor  
hDlg [87,90]. 
Recently,  other  PDZ  containing  proteins  that  interact  with  Tax-1  PBM  were  reported  [91].  Of 
particular interest, these authors found that syntenin-2 interacts with Tax-1 by its PDZ domain and 
co-localizes  with  Tax-related  nuclear  bodies,  but  not  with  Tax-2.  It  is  known  that  syntenin-2  is 
physiologically  targeted  to  nuclear  speckles  through  its  strong  PDZ  interaction  with 
phosphatidylinositol  4,5-bisphosphate  (PIP2)  and  its  depletion  by  RNA  interference  impairs  cell 
viability and reduces the rate of cell division [92]. Syntenins are also involved in activation of NF-B 
after Src kinase activation [93] These data suggest a new important role for Tax-1 PBM in recruiting 
syntenin-2 in the Tax-related nuclear bodies, and promoting its function. 
4.2. Tax Ubiquitination and Sumoylation 
Ubiquitination and sumoylation have been shown to play a critical role in the cellular localization, 
function and protein-protein interactions of both Tax-1 and Tax-2 [70,72,94–96]. 
Five of ten lysine residues contained in Tax-1 sequence were found to be the major targets for these 
modifications (see Figure 3). Lys189 (K4), Lys197 (K5), Lys263 (K6), Lys280 (K7) and Lys284 (K8), 
all contained within Tax-1 C-terminal region, strongly contribute to the ubiquitination of the protein, 
while sumoylation takes place on Lys280 (K7) and Lys284 (K8) [75,76]. 
Figure 3. Comparison of Tax-1 and Tax-2 lysine content and modifications. Tax-1 lysines 
numbered 4, 5, 6, 7 and 8 have been proven to be the major sites for ubiquitination (Ub), 
while sumoylation occurs exclusively on the lysines 7 and 8 (SUMO). Acetylation occurs 
on lysine 10 (Ac). Lysines of Tax-2B from K1 to K10i are indicated. Lysine residues 
involved in Tax-2B modifications have not yet been precisely identified. 
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The role of ubiquitination and sumoylation in Tax-1 transactivating activity is clearly different. 
Tax-1 ubiquitination is involved in the activation of NF-B pathway through the binding with key 
factors  such  as  IKKγ  and  TAK-1  binding  protein  2  (TAB2),  with  the  subsequent  RelA  nuclear 
translocation [97,98]. 
Whether the poly-ubiquitination targets Tax to the proteasome or enhances its activity is still not 
clear, although Yan et al. [99] demonstrated that poly-ubiquitination of K63 stabilizes Tax-1 and this 
form is predominant in the cytoplasm. They also found that poly-ubiquitination of K48 is predominant 
in  the  nucleus  and  constitutively  targets  Tax-1  for  proteasomal  degradation.  Those  authors 
demonstrated that Tax-1 PBM interaction with PDLIM2 (PDZ and LIM domain protein 2, an ubiquitin 
E3 ligase containing a PDZ domain) directs cytoplasmic and nuclear Tax-1 to the nuclear matrix for 
ubiquitination-mediated degradation [99,100].  
Other cellular factors have been demonstrated to be important in the post-translational regulation of 
Tax, such as peptidyl prolyl isomerase (Pin1) [84]. Pin1 prolongs the Tax-1 protein half-life by a 
mechanism that involves suppression of the ubiquitination and subsequent lysosomal degradation of 
Tax. Phosphorylated Tax-1 Ser160-Pro motif is recognized by Pin1 at the mitotic phase [84]. 
On the other hand, Tax-1 sumoylation is required to recruit RelA and IKKγ in Tax-1-related nuclear 
bodies, where Tax-driven transcription is promoted [74,76,94,101].  
These  data  suggest  that  Tax-1  ubiquitination  is  a  key  event  for  controlling  Tax-1 
cytoplasmic/nuclear  functions,  whereas  Tax-1  sumoylation  is  essential  for  its  nuclear  activity. 
Nonetheless, the predominance of ubiquitinated forms of Tax in the cytoplasm and of sumoylated 
forms in nuclear bodies is not a static event and can be affected by various signals. For example, it has 
been  hypothesized  that  DNA  damage  regulates  post-translational  modifications  of  Tax  and, 
consequently, its protein-protein interaction and localization [102]. 
Much less information has so far been obtained regarding Tax-2 post-translational modifications. 
We have recently demonstrated that Tax-2B is ubiquitinated and sumoylated similarly to Tax-1, even 
though  with  lower  levels  of  mono-sumoylated,  di-sumoylated  and  tri-sumoylated  forms  [72].  At 
variance  from  Tax-1,  Tax-2  contains  four  additional  lysine  residues.  The  lysines  involved  in  the 
modulation of Tax-1 activity are clearly defined, whereas the information for Tax-2B is still open 
(Figure 4).  
4.3. Tax Acetylation 
Tax-1 acetylation is known to be crucial for activating its functional properties, together with other 
post-translational modifications [83]. In particular, Ser-300/301 phosphorylation is a prerequisite for 
Tax-1  acetylation  promoting  its  presence  in  the  nucleus.  Sumoylation  is  also  necessary  for  the 
formation of Tax nuclear bodies where acetylation of the Tax-1 is performed by the transcriptional 
coactivator p300 [83]. 
Tax-1 acetylation results in the promotion of ATF/CREB and NF-κB pathways, probably by the 
activation of promoters integrated in the chromatin [83]. Tax-1 K10 (Lys346) (Figure 3), has been 
described as the only target of acetylation. Even though Tax-2 acetylation has not yet been studied in 
detail, evidence of its acetylation has already been obtained [83]. Viruses 2011, 3                         
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Figure  4.  Comparison  of Tax-1 and Tax-2 subcellular localization. Tax-1 and Tax-2B 
subcellular localization in 293T cells 24 h after transfection with vectors expressing both 
proteins.  The  cells  were  fixed  and  stained  by  immunofluorescence  with  anti-Tax-1  or  
anti-Tax-2B  and  analyzed  by  laser  scanning  confocal  microscopy.  Nuclear  stain  was 
performed using Hoechst stain. 
 
5. Cellular Localization of Tax Proteins 
The pleiotropic activity of Tax proteins is characterized by specific interactions with cellular factors 
in the nucleus and in the cytoplasm. Consequently, there are specific mechanisms that modulate the 
cellular trafficking of these proteins. A number of studies have reported nucleo-cytoplasmic shuttling 
of Tax-1 and functional effects of subcellular localization of Tax, although the regulatory mechanisms 
of its intracellular distribution remain to be clarified [53]. In a recent work, the role of a histone 
methyltransferase  (HMTase)  SMYD3  in  the  regulation  of  Tax-1  nucleo-cytoplasmic  shuttling  has  
been  reported  [103].  They  showed  that  the  interaction  between  Tax  and  SMYD3  regulates  the  
sub-cellular localization of Tax, as a consequence of SMYD3 shuttling and modifying Tax-mediated  
NF-B activation. 
Nuclear import-export of Tax-1 is both carrier and energy independent and relies on the interaction 
between Tax-1 and the p62 nucleoporin. This interaction is mediated by the amino terminal zinc-finger 
motif of Tax-1. Several mutations within this motif abolishes Tax1 interaction with p62 and nuclear 
import [104]. 
Initial studies on the intracellular distribution of Tax-1 indicated that it was localized essentially in 
the  nucleus  [22,33,34,86,105].  Using  different  cell  lines,  Tax-1  was  then  found  to  be  prevalently 
present in subnuclear domains, which overlap with structures previously identified as interchromatin 
granules  or  spliceosomal  speckled  structures.  These  structures  correspond  to  a  subset  of  nuclear Viruses 2011, 3                         
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transcriptional hot spots. The inclusion of the two subunits of NF-κB, p50 and RelA, and the presence 
of the mRNA from a gene specifically activated by Tax through NF-κB binding, suggested that these 
unique  nuclear  structures,  called  nuclear  bodies,  participate  in  Tax-mediated  activation  of  gene 
expression via the NF-κB pathway [74].  
However, other studies have reported Tax-1 cytoplasmic  localization in a number of cell  lines 
including Tax-1-transfected and HTLV-1-infected cells [106–108]. In the cytoplasm, Tax-1 targets  
I-Bα  and  I-κBβ  for  phosphorylation,  ubiquitination,  and  proteasome-mediated  degradation, 
promoting the nuclear translocation of NF-κB/Rel proteins and the transcription induction of many 
cellular  genes  [109].  More  specifically,  cytoplasmic  Tax-1  was  demonstrated  to  localize  within 
organelles associated with cellular secretory pathways, including the endoplasmic reticulum and the 
Golgi complex. [43]. 
Tax-1 is accumulated in close association with the Microtubule Organizing Center (MTOC) and is 
found in the cell-cell contact regions that organize virological synapses formed between an infected 
donor cell and a target cell [110,111]. In PBMCs derived from HTLV-1 infected patients, the fraction 
of Tax-1 present at the MTOC is closely associated with the cis-Golgi compartment [112]. 
Tax-2 intracellular localization has been studied by several authors and it was initially reported to 
be predominantly localized in the cytoplasm [30,35,36,51,113] with no clear evidence of localization 
within the nuclear bodies. However, using novel systems to compare concomitantly Tax-1 and Tax-2, 
we have demonstrated that Tax-2B is also present in nuclear bodies [72]. The comparison between 
Tax-1 and Tax-2 intracellular distribution is exemplified in Figure 4, obtained by using a new specific 
antibody  against  Tax-2  [114]).  It  is  evident  that  the  proteins  are  localized  in  both  nuclear  and 
cytoplasmic compartments, but Tax-2 is more markedly distributed in the cytoplasm. Localization 
within  the  nuclear  bodies  is  also  evident  for  both  proteins,  though  those  produced  by  
Tax-1 are more prominent and copious. 
From the functional standpoint, it is important to note that the Tax proteins are targeted to native 
TAB2-containing  cytoplasmic  structures,  which  are  reorganized  to  include  RelA  and  calreticulin 
following expression of Tax proteins [70]. In addition to TAB2 and RelA, other significant factors 
such  as  TAX1BP1  and  IKKγ  have  been  recently  detected  in  the  dotted  cytoplasmic  structures 
containing Tax [70]. 
6. Concluding Remarks  
Much attention has been dedicated to the understanding of the functional and structural properties 
of  Tax  proteins  and  in  particular  of  Tax-1.  All  the  different  facets  of  its  structural  domains,  its 
interaction  with  cellular  factors  and  corresponding  deregulation  of  transduction  pathways,  its 
intracellular  distribution  as  well  as  its  post-translational  modifications,  have  been  critically  and 
minutely dissected (for a recent review, see [20]). Much less is known for Tax-2, even though a more 
advanced comparative analysis between the two proteins could be of particular interest in reaching a 
better understanding of the differential pathogenic potential between HTLV-1 and HTLV-2. 
In Table 2 we have summarized the main functional and structural differences between Tax-1 and 
Tax-2. Besides the notable differences in transformation and expression capacities, there are two basic 
structural features that differentiate Tax-1 from Tax-2: the presence only in Tax-1 of a NF-κB2 domain Viruses 2011, 3                         
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and a PDZ binding motif, responsible for the binding to p100 and several PDZ-containing proteins, 
respectively [49]. 
Table 2. Summary of main functional and structural differences between Tax-1 and Tax-2. 
  Tax-1  Tax-2
a  Reference 
Transactivating activity  Higher  Lower  [113] 
Transformation capacity  Higher  Lower  [21] 
Micronuclei formation  +  −  [113] 
Cell cycle arrest  +  −  [23] 
Hematopoiesis suppression  +  −  [13] 
Reduction of histone gene expression  +  −  [24,25] 
Inhibition of p53 functions  Higher  Lower 
[26,115] 
[80] 
Total viral mRNA expression  Higher  Lower  [29] 
Proinflammatory cytokine expression  Higher  Lower  [11] 
Presence of PDZ motif  +  −  [1] 
Interaction with PDZ binding proteins  +  −  [20] 
Presence of NF-κB2 protein domain  +  −  [49] 
Interaction with p100  +  −  [49] 
Preferential cellular localization  Nucleus  Cytoplasm  [72] 
NF-B transactivation (lipid raft translocation of IKK)  +  −  [70] 
In vitro CK2 phosphorylation  +  −  [87] 
Oligo-sumoylation  +  −  [72] 
Nuclear bodies  Larger  Smaller  [72] 
a The properties of Tax-2 include both the results of Tax-2A and Tax-2B reported in the literature.  
 
Central to the question of subcellular localization is the issue of post-translational modifications of 
both proteins. The recent findings that Tax-2 is also modified by ubiquitination and sumoylation [72] 
and that both proteins present similar interaction capacity with specific cellular factors [70] have shed 
light  on  the  existence  of  a  common  intracellular  distribution  and  interactome,  as  depicted  in  the 
scheme of Figure 5. Poly-Ubiquitination (ubiquitination on Lys63) is a crucial step in maintaining  
Tax-1 within the cytoplasm [99], followed by its transport into the ER together with RelA, IKK, 
TAB2 and TAX1BP1 and poly-ubiquitination on Lys48, promoted by PDLIM2, leads Tax-1 to nuclear 
matrix for proteasomal degradation [99,100].  
Possible  other  ways  leading  to  the  Golgi,  to  the  MTOC  and  to  secretion,  still  await  further 
confirmation, especially for Tax-2. The sumoylation process is key to nuclear entry and maintenance, 
and a prerequisite for Tax localization within the Tax-related nuclear bodies. This post-translational 
modification  appears to  represent  a  subtle  difference  between  the  two  proteins,  inasmuch  as  only  
poly-sumoylated forms are clearly evident for Tax-2 [72]. Furthermore, no evidence for Tax-2 CK2 
phosphorylation has so far been obtained [87].  
More insights and efforts are therefore needed to single out possible differences between Tax-1 and 
Tax-2 in the post-translational processing and in obtaining a more precise identification of the amino 
acid residues directly involved in the modifications of the two proteins. Viruses 2011, 3                         
 
 
552 
Figure  5.  A  model  for  Tax  trafficking  in  the  cell.  The  figure  shows  the  intracellular 
distribution of Tax-1 after ubiquitination and sumoylation post-translation modifications. 
Tax-1 colocalizes in calreticulin stained dotted structures including TAB2, RelA, IKKγ and 
TAX1BP1 in endoplasmic reticulum (ER). In the cytoplasm, ubiquitinated Tax activates 
IKK signaling, resulting in the translocation of the NF-B RelA factor to the nucleus. The 
de-ubiquitinated Tax  migrates to  the nucleus where it is sumoylated and assembled in 
nuclear bodies that include the RelA and IKKγ. Tax-1 poly-ubiquitination on K48 targets 
Tax-1  for  proteasomal  degradation,  after  interacting  with  PDLIM2.  The  scheme  also 
proposes the trafficking of Tax to the Golgi, the Microtubule Organizing Center (MTOC) 
and outside the cell (secretion).  
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